Position in EXEL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$802,900
+$216,192 QoQ
Shares Held
18,720
+39.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $6,272,368 across 181 Biotechnology names. EXEL ranks #1 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
This page
|
18,720 | $802,900 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,423 | $635,426 | |
| 3 | TECH |
BIO-TECHNE Corp
|
11,543 | $603,237 | |
| 4 | INCY |
Incyte Corp
|
6,007 | $565,378 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
613 | $473,628 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
2,012 | $380,368 | |
| 7 | MESO |
Mesoblast Ltd
|
24,425 | $375,656 | |
| 8 | CGEN |
Compugen Ltd
|
131,800 | $280,734 |
All Filings in EXEL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $802,900 | 18,720 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $586,708 | 13,386 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,806,582 | 67,956 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $619,588 | 14,056 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $93,149 | 2,523 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $37,629 | 1,130 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $29,323 | 1,130 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $20,537 | 914 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $13,051 | 550 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $13,194 | 550 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $12,017 | 550 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,510 | 550 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,675 | 550 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $8,822 | 550 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $8,624 | 550 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $11,451 | 550 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $12,468 | 550 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $10,054 | 550 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $11,627 | 550 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $10,021 | 550 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $11,038 | 550 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $13,447 | 550 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $13,057 | 550 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $4,735 | 275 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||